These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24784346)

  • 21. Peptide epitopes from the Wilms' tumor 1 oncoprotein stimulate CD4+ and CD8+ T cells that recognize and kill human malignant mesothelioma tumor cells.
    May RJ; Dao T; Pinilla-Ibarz J; Korontsvit T; Zakhaleva V; Zhang RH; Maslak P; Scheinberg DA
    Clin Cancer Res; 2007 Aug; 13(15 Pt 1):4547-55. PubMed ID: 17671141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. WT1 peptide vaccine stabilized intractable ovarian cancer patient for one year: a case report.
    Dohi S; Ohno S; Ohno Y; Takakura M; Kyo S; Soma G; Sugiyama H; Inoue M
    Anticancer Res; 2011 Jul; 31(7):2441-5. PubMed ID: 21873157
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Efficacy of WT1 peptide-/MUC-1 peptide-pulsed dendritic cell therapy in 313 patients with a wide range of cancers].
    Kato Y
    Gan To Kagaku Ryoho; 2014 Oct; 41(10):1280-2. PubMed ID: 25335717
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and analysis of mutations in WTX and WT1 genes in peripheral blood and tumor tissue of children with Wilms' tumor.
    Wang H; Shen Y; Sun N; Jiang YP; Li ML; Sun L
    Chin Med J (Engl); 2012 May; 125(10):1733-9. PubMed ID: 22800892
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of dendritic cell vaccines pulsed with Wilms' tumour-1 peptide antigen on the survival of patients with advanced non-small cell lung cancers.
    Takahashi H; Okamoto M; Shimodaira S; Tsujitani S; Nagaya M; Ishidao T; Kishimoto J; Yonemitsu Y;
    Eur J Cancer; 2013 Mar; 49(4):852-9. PubMed ID: 23245331
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunotherapy for leukemia cells by using cytotoxic T lymphocyte specifically against WT1-derived peptide: an experimental study in vitro].
    Gu WY; Cao XS; Qiu GQ; Chen ZX; Sheng LX; Xie XB; He J; Cen JN; Shen HL
    Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(49):3475-80. PubMed ID: 16686063
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dendritic cell immunotherapy in uterine cancer.
    Coosemans A; Tuyaerts S; Vanderstraeten A; Vergote I; Amant F; Van Gool SW
    Hum Vaccin Immunother; 2014; 10(7):1822-7. PubMed ID: 25424788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Wilms' tumor antigen is a novel target for human CD4+ regulatory T cells: implications for immunotherapy.
    Lehe C; Ghebeh H; Al-Sulaiman A; Al Qudaihi G; Al-Hussein K; Almohareb F; Chaudhri N; Alsharif F; Al-Zahrani H; Tbakhi A; Aljurf M; Dermime S
    Cancer Res; 2008 Aug; 68(15):6350-9. PubMed ID: 18676860
    [TBL] [Abstract][Full Text] [Related]  

  • 29. WT1 peptide vaccine for the treatment of cancer.
    Oka Y; Tsuboi A; Oji Y; Kawase I; Sugiyama H
    Curr Opin Immunol; 2008 Apr; 20(2):211-20. PubMed ID: 18502632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Immunotherapy in Acute Leukemias: Implications and Perspectives Using Wt1 Antigen.
    Cebinelli GC; DE Sousa Pereira N; Sena MM; DE Oliveira CE; Fujita TC; DA Rocha SP; DE Abreu Oliveira FJ; Marinello PC; Watanabe MA
    Anticancer Res; 2016 Aug; 36(8):3795-802. PubMed ID: 27466479
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Generation and Cryopreservation of Clinical Grade Wilms' Tumor 1 mRNA-Loaded Dendritic Cell Vaccines for Cancer Immunotherapy.
    Smits EL; Stein B; Nijs G; Lion E; Van Tendeloo VF; Willemen Y; Anguille S; Berneman ZN
    Methods Mol Biol; 2016; 1393():27-35. PubMed ID: 27033213
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Cancer antigen WT1-targeting treatment for the malignancies].
    Oka Y; Kawase I
    Nihon Rinsho Meneki Gakkai Kaishi; 2008 Oct; 31(5):375-82. PubMed ID: 18974621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Th1-biased humoral immune responses against Wilms tumor gene WT1 product in the patients with hematopoietic malignancies.
    Wu F; Oka Y; Tsuboi A; Elisseeva OA; Ogata K; Nakajima H; Fujiki F; Masuda T; Murakami M; Yoshihara S; Ikegame K; Hosen N; Kawakami M; Nakagawa M; Kubota T; Soma T; Yamagami T; Tsukaguchi M; Ogawa H; Oji Y; Hamaoka T; Kawase I; Sugiyama H
    Leukemia; 2005 Feb; 19(2):268-74. PubMed ID: 15538407
    [TBL] [Abstract][Full Text] [Related]  

  • 34. EGR-1 enhances tumor growth and modulates the effect of the Wilms' tumor 1 gene products on tumorigenicity.
    Scharnhorst V; Menke AL; Attema J; Haneveld JK; Riteco N; van Steenbrugge GJ; van der Eb AJ; Jochemsen AG
    Oncogene; 2000 Feb; 19(6):791-800. PubMed ID: 10698497
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The WT1 gene--its role in tumourigenesis and prospects for immunotherapeutic advances.
    Lindstedt I; Lindgren MA; Andersson E; Engström W
    In Vivo; 2014; 28(5):675-81. PubMed ID: 25189877
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sensitive detection of rare antigen-specific T cells directed against Wilms' tumor 1 by FluoroSpot assay.
    Danielzik T; Koldehoff M; Buttkereit U; Beelen DW; Horn PA; Lindemann M
    Leuk Lymphoma; 2018 Feb; 59(2):490-492. PubMed ID: 28573960
    [No Abstract]   [Full Text] [Related]  

  • 37. [WT1 peptide-based immunotherapy].
    Sugiyama H
    Nihon Rinsho; 2005 Jun; 63(6):1101-9. PubMed ID: 15948398
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of a highly immunogenic HLA-A*01-binding T cell epitope of WT1.
    Asemissen AM; Keilholz U; Tenzer S; Müller M; Walter S; Stevanovic S; Schild H; Letsch A; Thiel E; Rammensee HG; Scheibenbogen C
    Clin Cancer Res; 2006 Dec; 12(24):7476-82. PubMed ID: 17189421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. WT1 in acute leukemia, chronic myelogenous leukemia and myelodysplastic syndrome: therapeutic potential of WT1 targeted therapies.
    Rosenfeld C; Cheever MA; Gaiger A
    Leukemia; 2003 Jul; 17(7):1301-12. PubMed ID: 12835718
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The role of Wilms' tumor genes.
    Hirose M
    J Med Invest; 1999 Aug; 46(3-4):130-40. PubMed ID: 10687307
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.